We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...

The Food and Drug Administration approved Amgen Inc ‘s AMGN Lumakras (sotorasib) in combination with Vectibix (panitumumab) ...

Amgen Inc (AMGN) stock saw a modest uptick, ending the day at $268.94 which represents a slight increase of $1.84 or 0.69% from the prior close of $267.1. The stock opened at $269.33 and touched a low ...

In the most recent trading session, Amgen (AMGN) closed at $267.10, indicating a -1.14% shift from the previous trading day.

Today, Benzinga's options scanner spotted 11 options trades for Amgen. This isn't normal. The overall sentiment of these ...

Amgen Inc (AMGN) stock saw a modest uptick, ending the day at $270.19 which represents a slight increase of $7.96 or 3.04% from the prior close of $262.23. The stock opened at $262.11 and touched a ...

Amgen (NASDAQ:AMGN – Get Free Report) had its target price dropped by equities research analysts at Wells Fargo & Company ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $310.00. The ...

Harbor Capital Advisors Inc. increased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.5% during the ...

On Wednesday, Goldman Sachs reiterated its Buy rating on Amgen stock (NASDAQ:AMGN), maintaining a price target of $370.00. The biotechnology giant, with a market capitalization of $143.57 billion ...